Article
miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1
Cancer Management and Research · 2019 · Peng D, Dong J, Zhao Y, Peng X, Tang J, Chen X, Wang L, Hu DN, Reinach PS, Qu J, Yan D
Key facts
| Title | miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1 |
|---|---|
| First author | Peng D, Dong J, Zhao Y, Peng X, Tang J, Chen X, Wang L, Hu DN, Reinach PS, Qu J, Yan D |
| Journal | Cancer Management and Research |
| Published | May 24, 2019 |
| DOI | 10.2147/CMAR.S206461 |
| Devices mentioned | K800552, K812133, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 11 more |
| Product codes mentioned | EPT, FSM, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, NSU and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1